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INTRODUCTION
Transmissible gastroenteritis virus (TGEV), that belongs to the Coronaviridae family, causes gastroenteritis in pigs resulting in high mortality and morbidity in neonates (Spaan et al., 1988) . Within this family, TGEV forms an antigenic cluster with feline infectious peritonitis virus (FIPV), feline en-teric coronavirus (FECV), canine coronavirus (CCV), and porcine respiratory coronavirus (PRCV) ( S~inchez et al., 1990 ) . Vaccines developed against transmissible gastroenteritis (TGE) are not efficient (Moxley et al., 1989) . TGEV has three structural proteins: the spike (S), the nucleoprotein (N), and the membrane (M) protein (Jim6nez et al., 1986; Spaan et al., 1988) . Protein S is the major inducer of TGEV neutralizing antibodies. In this protein, four antigenic sites (A, B, C, and D) have been defined by mutual competition of monoclonal antibodies (mAbs). Site A is antigenically dominant and has been divided into three antigenic subsites: Aa, Ab, and Ac . Three of the antigenic sites overlap with the sites described by others Delmas et al., 1990) . Sites A and D, and to a minor extent site B, have been involved in the neutralization ofTGEV (Delmas et al., 1986; Jim6nez et al., 1986) , and the mechanisms of TGEV neutralization have been described .
We have focused on the analysis of the different antigenic sites because of their importance in determining the molecular basis of virulence and immunoprotection against TGE. More specifically, we have studied the correlation between the antigenic and physical structure of the S glycoprotein. Since protection against TGE requires lactogenic immunity, the presentation of the selected antigens to the immune system by vectors with tropism for gut associated lymphoid tissues (GALT), such as Salmonella typhimurium and adenovirus, has been selected as a convenient immunization strategy.
MATERIALS AND METHODS

Cells, viruses, mAbs, and mAb resistant (mar) mutants
The characteristics of the viruses and the cells on which they were grown, and ofmAbs have been reported (Jim6nez et al., 1986; Siinchez et al., 1990) . For simplicity, the viruses have been frequently named with three letters derived from their place of isolation and two digits which refer to the year of isolation. TGEV titration, neutralization and purification, were performed as described Correa et al., 1990) . Mar mutants were selected and characterized as described (Jim6nez et al., 1986; Correa et al., 1988) .
Radioimmunoassay (RIA), competitive RIA (cRIA) and epitope scanning (PEPSCAN)
The procedures for the RIA and cRIA have been described previously . Optimum amounts of antigen (between 0.2 and 1.0/tg of protein per well) were used in the RIA and cRIA. PEPSCAN was performed with nonapeptides as described .
DNA and RNA sequencing DNA from Bluescript-TGEV plasmids and RNA purified from virions were sequenced by oligodeoxynucleotide primer extension and dideoxynucleotide chain termination procedure (Sanger et al., 1977; Fichot and Girard, 1990) . Sequence data were assembled and analyzed using the computer programs of the Genetics Computer Group (University of Wisconsin ).
Phylogenetic tree
Sequence information was analyzed following standard phylogenetic methods (Sfinchez et al., 1992) . The number of substitutions between each pair of nucleotide was estimated as described (Jukes and Cantor, 1969) . Two gaps introduced to align the sequences were excluded from the calculations. The epidemiological tree was constructed by the neighbour-joining method as implemented in the program TREEDIST (Saituo and Nei, 1987; Sourdis and Nei, 1988) , and by the least squares method as implemented in the program FITCH from the PHYLIP package, version 3.3 (Felsenstein, 1990) .
Cloning and expression of TGEV S gene in S. typhimurium and adenoviruses
S gene from TGEV and from mar mutants was first cloned into Bluescript SK-following customer (Stratagene) and standard procedures (Gebauer et al., 1991; Sambrook et al., 1989; Ausubel et al., 1991 ) . Expression in avirulent forms of Salmonella typhimurium Acya, Acrp, Aasd (Curtiss et al., 1990; Curtiss and Kelly, 1987; Nakayama et al., 1988 ) was made by cloning S gene on plasmid pYA292. The indicated nucleotide sequences of the S protein ( Fig.  5 ) were subcloned into plasmid pYA292 and transfected into E. coli Z6097F' [,~asd zJ (pro-lac) Cloning on human adenovirus 5 (Ad5) was performed using plasmids pSV2X3, pFGI44K3, pABI4 and pFG173 following described procedures (Graham and Prevec, 1992) . The indicated S gene fragments ( Fig. 6) were flanked by the SV-40 promoter, termination, and polyadenylation signals by cloning the inserts into pSV2X3 plasmid. SV-40 expression cassettes were flanked by Ad5 sequences by subcloning them into the former locations of the deleted E3 gene of Ad5 using plasmids pFGI44K3 and pABI4, which contains the 3'-end Ad5 sequences. Recombinant Ad5-TGEVs were rescued by cotransformation of human 293 cells by plasmids containing TGEV sequences and pFG 173.
Residues in volved in the antigenic sites of TGE V S glycoprotein
The residues contributing to the four antigenic sites of S glycoprotein were localized by sequence analysis of 21 mutants that escaped neutralization or binding by TGEV-specific mAbs, and by epitope scanning (Fig. 1 ) (Gebauer et al., 1991; Geysen et al., 1984) . Site A includes amino acids 538, 591 and 543, which are essential in the formation of subsites Aa, Ab and Ac, respectively. In addition, changes in amino acid 586 have partially altered both subsite Aa and Ab, indicating that these subsites overlap in residue 586. Other amino acids contribute to site B (residues 97 and 144), site C (residues 50 and 51 ), and site D (residue 385). The location of site D by sequence analysis is in agreement with epitope scanning techniques. Site C can be represented by peptides 48-P-P/S-N-S-D/E-52, it is not exposed on the surface of native virus, but its accesibility can be modulated by treatment at pH > 11 (at 4°C) or temperatures > 45°C. Sites A and B are fully dependent on glycosylation for proper folding, while sites C and D are independent of glycosyla- tion, respectively. Once the S glycoprotein has been assembled into the virion, the carbohydrate moiety is not essential for the antigenic sites.
Antigenic and genetic evolution of TGEV
The antigenic homology of 26 coronavirus isolates, of which 22 were related to TGEV has been determined with 42 mAbs (Sfinchez et al., 1990) . On the S protein, antigenic site A was highly conserved. Subsite Ac contains interspecies specific epitopes common to porcine, feline and canine coronaviruses. The other sites could be classified according to their degree of variability in the order C > B > D. Proteins N and M of these isolates shared many antigenic determinants. Binding of mAbs to different coronaviruses strongly suggests the classification of the human coronavirus 229E in a taxonomic cluster distinct from TGEV group.
Sequencing studies, in which 13 isolates of TGEV and PRCV were analyzed (S~inchez et al., 1992) showed that S proteins of the European and American PRCV isolates have deletions of 224 and 227 amino acids, starting at residues 21 and 22, respectively ( Fig. 2) S~inchez et al., 1992; Wesley et al., 1991 ) . The amino acid homology was higher than 98% either among the TGEV or the PRCV isolates. In contrast, the homology between TGEVs and PRCVs was around 1% lower (S~inchez et al., 1992) . Although this percentage difference is small, the almost identical location of the residues changed, makes this difference significant. The same overall degree of homology was found in the globular and fibrilar areas of the S protein.
Two conserved domains were identified in the globular portion of the peplomer protein of TGEVs and PRCVs, when the number of amino acid residues changed was plotted versus their position in the sequence of the S protein. The most conserved domain mapped between residues 181 and 243 of , 9r-t44 '>)8-:91
Summary of the deletions present in S glycoprotein of TGEVs and PRCVs. Letters and numbers show the antigenic sites and the amino acid residues on the protein, respectively. The position of the deletions is indicated by brackets. Virus sequences were taken from different publications (Britton and Page, 1990; Gebauer et al., 1991; Rasschaert et al., 1990; DeGroot et al, 1987; S~inchez et al., 1992) . The first six PRCV isolates listed were isolated in Europe, and the seventh one (IND89) in North America.
PRCV. The second most conserved area was located between amino acids 303 and 337 of PRCV (Sfinchez et al., 1992).
Based on the nucleotide sequence of the globular area of the spike protein of 6 PRCVs and 6 TGEVs, which were aligned for maximum fitness, an evolutionary tree has been proposed (Fig. 3) (Sfinchez et al., 1992) . This epidemiological tree predicts that the PUR46 isolate was originated from a putative recent progenitor, named TGEV-1, circulating around 1941. Since then,  from a main lineage, the isolates TOY56, MIL65, BRI70, and 
Receptor binding sites in TGE Vs
TGEVs have both enteric and respiratory tropism. In contrast, respiratory viruses as the PRCVs, have an almost exclusive respiratory tropism. Even by directly infecting the intestinal tract with the PRCVs, only a few cells are infected, which are different to the epithelial cells of the villi, susceptible to the enteric viruses (Cox et al., 1990a; Cox et al., 1990b) . These results imply that both types of viruses have different tropism. It could be proposed that the enteric or respiratory tropism of TGEV is conditioned by two receptor binding sites (RBS), located in the S protein (Fig. 4) . The receptor binding site conferring respiratory tropism (RBS-R) should map in an area present in both TGEVs and PRCVs, while the RBS conferring enteric tropism (RBS-E) would have full activity only in TGEV isolates. Candidate domains for the location of this RBS-R could be the highly conserved areas detected between amino acids 181 to 243, or 303 to 337 (residue numbers correspond to the position that these amino acids have in the PRCV sequence) (S~inchez et al., 1992) . In ST (swine testicle) cells, the RBS of TGEV probably maps within sites A and D, since mAbs specific for these sites inhibit the binding of the virus to ST cells . The RBS conferring the enteric tropism is probably located between amino acids 21 to 244, or a domain structurally influenced by one of these residues, since they were absent in all PRCV isolates sequenced (Fig. 2 ) S~inchez et al., 1992; Wesley et al., 1991 ) . Alternative explanations to understand the tropism of these viruses are also possible (see Discussion).
Representation of complex sites
Antigenic sites A and B are conformational and dependent on glycosylation (Gebauer et al., 1991 ) . Antigenic domains of these sites may be represented by small peptides. Subsite Ac is represented, at least partially, by peptide 537-MKSGYGQPIA-547, recognized by MAb 1A.F10 in the PEPSCAN assay (Gebauer et al., 1991 ) . This peptide might be of importance for diagnosis and protection, since epitope 1A.FI0 is located in subsite Ac, which is conserved in coronaviruses of three animal species (S~inchez et al., 1990 Fig. 4 . Hypothetical location in the S glycoprotein of receptor binding sites conferring respiratory (RBS-R) or enteric (RBS-E) tropism. Letters below the diagram show the position of the antigenic sites Gebauer et al., 1991 ) . The inhibition (%) of the binding of TGEV, strain PUR46-CC120-MAD, to ST cells is shown in the second line. Alternative models are not excluded (see Discussion). a recombinant DNA library expressing oligopeptides with a random sequence, we have selected hexapeptides mimicking sites B, C, and D (Lenstra et al., 1992) . These synthetic peptides frequently are useful for diagnostic purposes, although their use as immunogens is less obvious. MAb 6A.C3, specific for subsite Ac of S glycoprotein, neutralizes TGEV with high efficiency and recognizes an inter species-specific epitope. This mAb was used to induce internal image, anti-idiotypic MAbs mimicking epitope 6A.C3. These fl,-type anti-idiotypic mAbs induced in vivo TGEV neutralizing antibodies , and might be relevant in protection against TGE.
Cloning and expression of TGEV antigens in vectors to induce mucosal immunity
Secretory immunity is best induced by antigen presentation in GALT. An strategy to induce lactogenic immunity to protect against TGEV, might be the presentation of viral antigens using prokaryotic and eukaryotic vectors with tropism for Peyer's patches. We have selected S typhimurium and adenovirus to present TGEV antigens to the immune system.
Avirulent forms of S. typhimurium with potential use as vaccine carriers have been developed (Curtiss III et al., 1990; Curtiss III and Kelly, 1987; Nakayama et al., 1988) . These bacteria are double mutants, Acya and Acrp, unable to produce cAMP or its receptor (CRP). These mutants induce high immunity levels in mucosae and secretions. A third mutation, Aasd, introduced in Salmonella, affects the synthesis of diaminopimelic acid, an essential component of the bacterial wall, rendering non-viable bacteria. Cell viability can be obtained by transforming the asd-bacteria with expression plasmids asd +, as pYA292. This plasmid codes for lacZ gene, under the control of trc promotor. Three fragments of TGEV S gene, which taken together code for the whole S protein (Fig. 5 ) were cloned into the Y-end ofgene lacZ of three pYA292 plasmids (C. Smerdou, R. Curtiss, and L. Enjuanes, unpublished data). Smooth forms ofavirulent S. typhimurium (strain 2'3987) were independently transformed with the three plasmids, named: pYA-TS1, pYA-TS2, and pYA-TS3. In vivo protection studies using the transformed Salmonella are in progress.
A eukaryotic vector, AdS, has also been used to express TGEV antigens in mammalian cells both in vitro and in vivo. This expression system might provide the glycosylation pattern needed to express properly antigens like sites A and B, which are fully dependent on glycosylation for proper folding. Four DNA segments, coding for the whole S gene and for three truncated forms of this gene have been cloned on Ad5 (Fig. 6) The flanking restriction endonuclease sites and nucleotides of the S gene fragment, cloned into each plasmid, are indicated next to the dashed segments. Ptrc, trc promotor, asd, sequences complementing mutant phenotypes with requirement for threonine, methionine, and diaminopimelic acid; lacZ, fl-galactosidase gene; 5S, the 5S rRNA gene; TI and T2, the rrn-BT1T2 transcription terminators (Nakayama, et al., 1988 ; C. Smerdou, R. Curtiss III, and L. Enjuanes, unpublished results).
adenovirus (Graham and Prevec, 1991 ) . We have shown that porcine cell lines fully support the replication of the recombinant Ad5 with high efficiency. At present, we are evaluating the protection against TGE provided by these recombinant viruses.
DISCUSSION
The antigenic structure of the S glycoprotein of TGEV and its correlation with the physical structure has been described. In addition, the genetic homology among viruses of the TGEV antigenic cluster has been shown, and an evolutionary tree has been proposed, to establish the relationship among these viruses and their possible origin. Information on the antigenic structure and the conservation of the different sites involved in virus neutralization, allowed the selection of several antigenic determinants potentially involved in protection. S gene segments coding for these sites have been cloned in vectors with tropism for Peyer's patches, such as S. typhimurium and adenovirus, to test their role in protection against TGEV. The enterophathogenic TGEV was first isolated in 1946 (Doyle and Hutchings, 1946) . In 1984, a non-enteropathogenic virus, the PRCV, related to TGEV appeared. In contrast to TGEV, PRCV exhibited no clinical signs of disease (Pensaert et al., 1986; Callebaut et al., 1988) . The antigenic homology among isolates of TGEV and PRCV has been clearly documented (Callebaut et al., 1988; Garwes et al., 1988; Rasschaert et al., 1990; S~inchez et al., 1990; Wesley et al., 1990) . The analysis of the antigenic structure of TGEV S protein has shown that the half amino terminus is highly immunogenic and that it contains the four antigenic sites defined by two groups (Delmas et al., 1986; Correa et al., 1988; Correa et al., 1990) . In contrast, the PRCVs have lost sites B and C, due to a deletion of 224 or 227 amino acids in the S protein. This type of deletion has not been found in the fibrilar portion of the peplomer. Sites A and D are present in both enteric and respiratory viruses, and they are the major inducers of neutralizing antibodies. Hence, it could be expected that the variability in the globular portion of the S molecule might be higher than in the fibrilar domain. Although a few more nucleotide changes were concentrated in these sites, the overall homology in the globular and fibrilar domains was the same (S~inchez et al., 1992) .
A hypothetical receptor binding site conferring tropism for respiratory tissues has been located between sites A and D, as described above. The RBS-E conferring enteric tropism has been proposed to be located in the area missing in the PRCVs, which do not infect enteric tissues. Nevertheless, it can not be excluded that this RBS-E would be located in another domain that requires the presence of amino acids 21 to 249 to keep its functionality. An alternative explanation is the existence of a RBS which could adopt two conformations, depending on the sequence of distal domains of the S glycoprotein. These functional models assume that the ability of a virus to infect respiratory or enteric tissues, only depends on the presence of a receptor in the host cell which will recognize a RBS present on the virus. In contrast, it cannot be excluded that the expression of other genes such as those coding for the nonstructural proteins, is involved in the tropism of these viruses. Hence, more information is required before a definite location of the RBS (s) is made.
Based on sequence data and evolutionary tree has been proposed relating TGEVs and PRCVs (Fig. 3 ) (S~inchez et al., 1992 ) . Since we are dealing with a limited number of isolates from each continent, it might be anticipated that the inclusion of new isolates from other areas (e.g., Japan) could show that certain lateral branches would become main branches. A mutation fixation rate of 0.95 _+ 0.05 nucleotide substitutions per year, approximately constant with time has been shown, suggesting the existence of a well defined molecular clock (Kimura, 1983) . From the mutation fixation rate, and the number ofnucleotides considered, the number of substitutions per nucleotide and year can be estimated at 7_+2× 10 -4 . This rate falls into the range reported for other RNA viruses (Domingo and Holland, 1988) .
Two types of PRCVs have emerged since 1984, one in Europe and the other in North America. Both have a large deletion of different size, located in an slightly different position in the NH2-end of the S glycoprotein (Fig. 2) , suggesting that they were independently derived. This data indicates that around nucleotide 60 on the S gene, there might be a site susceptible to undergoing a recombination/deletion event. Hence, two mechanisms are possibly involved in the evolution of TGEV, recombination and point mutation.
Protection against TGE requires mucosal immunity. Two vector systems have been selected to focus the antigen in GALT, S. typhimurium and human adenovirus. Antibodies against these vectors are not usually present in adult swine, when the immunization has to be provided to pregnant sows. The use of the corresponding porcine strains (i.e.S. cholerae-suis or porcine adenoviruses) might not be adequate since the immunological status of the adult animal might prevent the transitory colonization or infection of the GALT.
